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Abstract
Background: MUTYH-associated polyposis (MAP) is a recessive, hereditary, colorectal cancer-predisposing syndrome
caused by biallelic mutations in the MUTYH gene. Most MUTYH pathogenic variants are missense mutations, and
until recently no gross genomic deletions had been described.
Case Presentation: We have identified a large deletion in the MUTYH gene: a > 4.2 kb deletion encompassing
exons 4-16. This is the second description of this rearrangement, which has been recently described as the first
large deletion in this gene. The clinically suspected MAP patient was homozygous for this mutation and presented
with no amplification products for 14 exons of MUTYH on initial screening. Deletion breakpoints were refined to
base pair level through array comparative genomic hybridization (aCGH) analysis followed by sequencing. The
identified breakpoints were located within intron 3 and 146 bp downstream of the 3’ end of the gene, with the
presence of an AluJr element adjacent to the distal breakpoint. The presence of a 2 bp insertion at the junction
suggests the involvement of the non-homologous end joining (NHEJ) repair mechanism, possibly facilitated by
rearrangement-promoting elements. Examination of the MUTYH locus revealed a high Alu density that may make
this region prone to rearrangements.
Conclusion: Large deletions are a possible mechanism for loss of function of the MUTYH gene, and investigation
of such mutations may be important in identifying causative mutations in MAP patients.
Background
MUTYH-associated polyposis (MAP) (MIM#608456), a
recessive inherited syndrome characterized by colorectal
adenomatous polyposis and a high risk of colorectal
cancer, is a disorder caused by biallelic pathogenic
germline variants in the human mutY homologue
(MUTYH) gene [1]. MUTYH spans 11.2 kb on chromo-
some 1p34.1 [2] and encodes a DNA glycosylase that
plays a key role in base excision repair (BER) of 8-oxoG:
A mismatches by removing the mismatched adenine [3].
The oxidation product 8-oxoG is the most stable pro-
duct of oxidative DNA damage [4], which can lead to G:
C to T:A transversions if not repaired
5. Tumorigenesis
in MAP patients is thought to be initiated by somatic G:
C ®T:A transversions in KRAS and/or APC [5].
The clinical manifestations of MAP resemble familial
adenomatous polyposis (FAP; MIM#175100), which is
caused by autosomal dominantly inherited pathogenic
variants in the APC gene. Most biallelic MUTYH muta-
tion carriers have between ten and several hundred
polyps, usually with later onset compared to FAP
patients [1,6]. Also, a number of MAP patients with
CRC and no polyps have been reported [5]. Mutations
in MUTYH account for approximately 40% of patients
with 10-100 colorectal adenomas (attenuated FAP
patients) and positive familial history, a proportion
slightly higher than that of APC mutations in these
patients (30%) [7].
Nearly 300 different sequence variants have been iden-
tified so far in this gene (MUTYH Leiden Open Varia-
tion Database; http://chromium.liacs.nl/LOVD2/
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trast to pathogenic APC variants, which mostly result in
a truncated or absent protein, most pathogenic MUTYH
variants are missense variants and only a minority con-
sists of splice site and truncating variants [2] The two
hotspot mutations p.Tyr179Cys (exon 7) and p.
Gly396Asp (exon 13) are prevalent in populations of
European origin, probably due to a founder effect, and
account for approximately 80% of all reported mutant
alleles [5,8]. In the Brazilian population, a recently pub-
lished paper on patients with clinical phenotypes of
MAP, FAP and Lynch syndrome identified 4/60 (6.6%)
patients with these two hotspot mutations in a biallelic
state [9]. Until recently, no gross genomic deletions or
duplications had been described in this gene in any
population.
Here, we report a case study in which we have charac-
terized a large MUTYH deletion in a MAP patient. Dur-
ing the composition of this manuscript, an independent
study performed by a French group identified this same
rearrangement in one of their polyposis patients [10].
We have refined the breakpoint of this > 4.2 kb deletion
to the base pair level. Based on the analysis of the
sequences at breakpoints, we suggest a possible mechan-
ism of origin for this alteration. Presence of this deletion
was also analyzed in familial colorectal patients and a
control group.
Case Presentation
A Brazilian female patient (FAP15) from the Hereditary
Colorectal Cancer Registry of Hospital AC Camargo
(São Paulo, Brazil), who was clinically suspected for
MAP, was screened for mutations in the MUTYH gene
by direct sequencing. The age at onset of the attenuated
polyposis (approximately 40 polyps) was 42 years and of
the rectal cancer was 44 years. No extracolonic manifes-
tations were observed in this patient. Family history was
accessed through personal report. The patient stated
that she had unaffected deceased parents, four
unscreened siblings (without colonoscopy) and one
affected sister from whom biological material was una-
vailable due to residence distance (Figure 1). The
affected sister presented with attenuated polyposis at the
age of 44 years. The proband had a Caucasian ancestry,
since her great-grandparents were Portuguese.
In addition, the presence of this MUTYH deletion was
screened through PCR in other 183 Brazilian individuals:
three APC/MUTYH-mutation negative and 18 APC/
MUTYH-mutation positive polyposis patients (12 APC
mutation carriers, 5 MUTYH biallelic and one MUTYH
monoallelic mutation carriers); 51 clinically suspected
Lynch syndrome patients (fulfilling Amsterdan II or
Bethesda criteria), who were non-carriers of germline
mutations in the mismatch repair (MMR) genes MLH1,
MSH2, MSH6 and PMS2; and 111 healthy controls.
Written informed consent was obtained from all
patients and controls. This study was approved by the
ethics committee of A. C. Camargo Hospital (approval
number: 1169/08-B).
Identification and characterization of the deletion
We detected a homozygous deletion encompassing
several exons of the MUTYH gene in this MAP
patient. Genomic DNA was obtained from blood using
the Puregene Genomic DNA Isolation Kit (Gentra Sys-
tems, USA) according to manufacturer’s instructions.
Figure 1 Family tree of patient FAP15. The proband is indicated by the arrow. The proband’s age at onset of the polyposis (42 years) and of
the rectal cancer (44 years) are indicated. The patient presented unaffected deceased parents, four unscreened (without colonoscopy) siblings
and one affected sister. The affected sister presented with polyposis at the age of 44 years. The Caucasian patient stated having Portuguese
great-grandparents and no report of inbreeding in her family.
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Page 2 of 6Eleven primer pairs were designed to amplify all 16
exons of MUTYH gene (NM_001128425.1), including
intron-exon boundaries. Primers used for these ana-
lyses and PCR conditions are available upon request.
Unexpected results were observed when performing
standard PCR for MUTYH mutation screening on this
patient; exons 3-16 could not be amplified (data not
shown). As a positive control for the reaction, multi-
plex PCR in the presence of primers for control genes
(GAPDH intron 7; HPRT1 exon 3) was performed for
each MUTYH exon and confirmed the absence of
genomic template for this gene. The results of multi-
plex PCR for the patient and a control DNA are
s h o w ni nF i g u r e2 A .
With the purpose of elucidating the extent of the dele-
tion, comparative genomic hybridization based on
microarrays (aCGH) was performed. Briefly, samples
were labeled with Cy3- and Cy5-dCTPs by random
priming. Experiments were performed in duplicate using
a 180 K whole-genome platform (OGT Technologies).
Purification, hybridization, and washing were performed
as recommended by the manufacturer. Data extraction
was conducted using the Feature Extraction software
(Agilent Technologies). We applied the Genomic Work-
bench software (Agilent Technologies) for identifying
the constitutive genomic imbalances using the statistical
algorithm ADM-2, with a sensitivity threshold of 6.7, a
threshold log2 ratio of 0.4 or 1.1 for duplication or high
Figure 2 Homozygous deletion and characterization of the breakpoint in patient FAP15. A: Agarose gel of multiplex PCR performed for
MUTYH exons 1 to 16 (E1-E16) and control genes GAPDH or HPRT1. The patient (FAP15) exhibited absence of amplification for MUTYH exons 3
to 16, whereas a healthy individual (Control) presented all expected fragments. B: The blue line on the profile of chromosome 1 (bottom panel)
indicates the mapping at 1p34.1 of the two intragenic probes with log2 ratio values compatible with a homozygous deletion (green circles,
upper panel); probes flanking this deletion (at 5’ of MUTYH, and downstream of its 3’ end) exhibited normal values. The red arrow indicates the
position of probe A_14_P118536 where novel reverse primers were designed. C: Schematic drawing of the normal gene with genomic and
cDNA (NM_001128425.1) positions of the breakpoints. D: Schematic drawing of the deleted gene and primer locations (2F primer: chr1:
45800257-45800276; 16R1 primer: chr1: 45794388-45794407). E: Agarose gel showing the amplification of the deletion junction in the patient
and amplicon absence in the control DNA pool. F: Partial chromatogram of the junction sequencing showing in highlight the two inserted
nucleotides (TA). G: Nucleotide sequence around the deletion breakpoints and the deletion junction. Red larger nucleotides are the non-
template insertion (filler DNA). Light gray nucleotides indicate the deleted sequence. Shaded nucleotides represent shared sequences between
the breakpoints. Rearrangement-promoting elements GAG/GCS* are shown underlined. The gray arrow beneath the intergenic deleted sequence
shows the location of the AluJr element. *S denotes the ambiguity code symbol for G/C. Coordinates at chromosome 1 are given according
UCSC Feb. 2009 (GRCh37/hg19) assembly.
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Page 3 of 6copy number gain, and -0.4 and -1.1 for deletion and
homozygous loss, respectively.
Data analysis detected two sequences mapped within
the MUTYH gene that exhibited log2 ratio values com-
patible with a homozygous deletion (oligoprobes
A_14_P107667, mapped at chr1:45794902-45794961,
and A_14_P122926, at chr1:45797594-45797640; coordi-
nates given according to UCSC Feb. 2009 (GRCh37/
hg19) assembly) (Figure 2B). Oligoprobes flanking the
deletion at the 5’ end of MUTYH gene sequence and
downstream of the 3’ end had log2 ratios values consis-
tent with two copies (A_14_P122926-chr1:45804348-
45804405, and A_14_P118536-chr1:45793780-45793830)
(Figure 2B). Using an exon 2 forward primer (5’-
GGTGGATGAGAGGGAGATAG-3’) and reverse pri-
mers designed on the position of the A_14_P118536
undeleted probe and 600 bp upstream (primers 16R2:
5’-CTTCAGGTCTTCACCAAGTCC-3’ and 16R1: 5’-
CTTCTCCTGTGCTTCCTCTC-3’, respectively), we
successfully amplified the junction fragments for this
deletion. After confirming that the primer 16R1 was
located at an undeleted region and as it was closest to
the breakpoint, further analyses were performed only
with this primer. The PCR reaction of the control DNA
pool failed to amplify any detectable PCR product (theo-
retically 5889 bp in length), whereas PCR products of ≈
1600 bp were detected using genomic DNA from the
patient (Figure 2E). Briefly, the PCR conditions con-
sisted of 25 ng of genomic DNA, 0.3 μmol of each pri-
mer and 1X Platinum
® PCR SuperMix High Fidelity
(Invitrogen) in a 20 uL reaction. Cycling conditions
entailed a preincubation at 95°C for 2 minutes followed
by 35 cycles of denaturation at 95°C for 20 seconds,
annealing at 62°C and extension at 72°C for 2 minutes.
Direct sequencing of the junction fragments identified
the exact breakpoints (genomic position: chr1:
g.45,794,768_45,799,052del4285insTA, cDNA position:
c.348+33_*64+146del4285insTA), the precise size of the
deletion interval (4,285 kb) and the affected exons (4-
16) (Figure 2C and 2D). Genomic positions were con-
firmed using MUTALYZER 2.0 software. Previously,
exon 3 appeared to be deleted in the PCR analysis
because the breakpoint is located upstream of the
reverse primer site. No region of the adjacent HPDL
gene is deleted downstream of the 3’ end of MUTYH.
As the patient investigated in this study presented a
homozygous mutation and reported no inbreeding in
her family, we examined the presence of this deletion
among 111 healthy controls, 21 polyposis patients and
51 patients with familial CRC negative for mutations on
MMR genes. The junction fragment could not be ampli-
fied from the DNA of any other patient or control (data
n o ts h o w n ) .O n ep o s s i b l ee x p l a n a t i o nf o rt h eh o m o z y -
gous occurrence of the deletion in this patient, without
consanguineous parents, is the inheritance of two alleles
of a founder mutation in the population. The proband’s
great-grandparents were Portuguese, therefore she had
Caucasian ancestry. In this sense, very recently this
same deletion was found in a European MAP patient in
compound heterozygosity with the common MUTYH
Caucasian mutation p.Gly396Asp [10]. The description
of the same rearrangement in patients from different
geographic regions is a very exciting discovery and addi-
tional studies to uncover the origin and frequency of
this mutation would be of great value. Another potential
explanation for the homozygosity is the occurrence of
isodisomy, a type of uniparental disomy that results in
two identical segments from one parental homologue
and can occur due to a recombination event in the
zygote,, though the existence of an affected sibling does
not support this hypothesis.
Analysis of the junction sequence revealed several
important features, including an insertion of 2 bp of
non-template DNA (Figure 2F), several recombination
motifs such as GCG and GAS [11] and the presence of
an AluJr element located 2 bases upstream of the distal
breakpoint (Figure 2G). No repetitive element is present
at the upstream breakpoint. Examination of the
MUTYH locus using the Repeat-Masker software http://
www.repeatmasker.org/ revealed an Alu density of 22.2%
for an 11,800 kb region (chr1:45,794,343-45,806,142),
which includes the entire gene (11,229 bp), and 571 bp
downstream, which encompasses the distal breakpoint
characterized in this study (Figure 3).
This study is particularly important from both a clini-
cal and research perspective because we have identified
the first large intragenic deletion in MUTYH: a 4.285 kb
homozygous deletion in a MAP patient (c.[348+33_*64
+146del4285insTA];[348+33_*64+146del4285insTA]).
This mutation was submitted to the MUTYH LOVD
Mutation Database and has been publicly available since
May 12th: http://chromium.liacs.nl/LOVD2/colon_can-
cer/variants.php?select_db=MUTYH&action=view&-
view=1012041%2C0002450%2C10. The patient
presented a homozygous deletion encompassing exons 4
to 16 detected and mapped through PCR, aCGH and
sequencing. Breakpoints were sequenced and analysis of
the junction sequence allowed us to postulate that clas-
sical nonhomologous end joining (NHEJ) is the most
likely mechanism responsible for the deletion, as a 2-bp
non-template insertion sequence is observed at the
breakpoint junction [12,13]. This repair process involves
t h ed o u b l es t r a n db r e a k a g eo fD N Af o l l o w e db ye n d
joining in the absence of extensive sequence homology,
and is associated with small insertions at the junction
sites [14] and with very short stretches of sequence
identity (a few bp) between the two ends of the break-
point junctions [15]. Analysis of breakpoints
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adjacent to the distal breakpoint and the existence of
recombination/deletion promoting motifs [11] such as
GAG and GCS trinucleotides. These motifs are known
DNA polymerase pause-site core elements [16] and
might have facilitated deletion.
In silico analysis of the Alu content in the MUTYH
gene region revealed a high ratio of Alu sequences per
kb, with Alu elements occurring once in every 1.8 kb
(22.2%) when compared with the average of the human
genome where Alu elements account for about 10% and
occur once every 3 kb [17]. A recent study of more than
20 genes found evidence that a high content of transpo-
sable elements causes increased frequency of gene dis-
ruption by gross deletions in human disease [18].
Additionally, the local enrichment of Alus has been
observed in regions with recurrent Alu-mediated rear-
rangements, e.g., the VHL locus in von Hippel-Lindau
disease patients [19], and in genes implicated in colorec-
tal cancer-predisposing disorders such as Lynch and
Peutz-Jeghers syndromes (EPCAM-MSH2 [20] and
STK11 [21], respectively). However, not every Alu-rich
gene is prone to this type of deletion formation. Exam-
ples include the thymidine kinase or b-tubulin genes
[20,22]. In the MUTYH gene, a recent study has shown
that a polymorphic AluY insertion in intron 15 when in
a homozygous state, leads to a 2.15 fold increase in the
levels of 8-oxoG in leukocyte DNA and is associated
with type 2 diabetes mellitus [23]; however, this inser-
tion has not yet been studied in the context of colorec-
tal cancer.
Conclusions
Currently, there is no information on the percentage of
defects in the MUTYH gene caused by deletions/dupli-
cations of complete exons, and screening for this type of
mutation is not a common practice as it is with the
APC gene. Our finding highlights the importance of per-
forming screening methods, such as qPCR, MLPA or
long-range PCR, for large MUTYH deletions in polypo-
sis patients. Furthermore, it remains to be addressed
whether the high density of Alu elements in this gene
can cause an elevated frequency of Alu-mediated dele-
tions and rearrangements. Nevertheless, the evidence
shown here suggests that deletions could represent an
important mechanism of loss of function in the
MUTYH gene.
Consent
Written informed consent was obtained from all
patients and controls for publication of this case report
and any accompanying images. Copies of the written
consents are available for review by the Editor-in-Chief
of this journal.
Acknowledgements and Funding
The authors acknowledge the patients for their collaboration, the Nucleic
Acid Bank of A. C. Camargo Hospital for sample processing and Bianca C. G.
Lisboa for guidance in establishing the sequencing protocols. This work was
supported by National Institute of Science and Technology in
Oncogenomics (INCITO)-FAPESP: 2008/57887-9.
Author details
1International Center of Research and Training (CIPE), A. C. Camargo Hospital,
São Paulo, SP, Brazil.
2National Institute of Science and Technology in
Oncogenomics (INCITO), São Paulo, SP, Brazil.
3Colorectal Tumors
Department, A. C. Camargo Hospital, São Paulo, SP, Brazil.
4Barretos Cancer
Hospital-Pio XII Foundation, Barretos, São Paulo, Brazil.
Authors’ contributions
GTT designed and performed the molecular genetic studies and drafted the
manuscript. FCCS participated in the experimental design and revised the
manuscript critically. ACVK carried out the aCGH analysis and revised the
manuscript critically. EMMS participated in the clinical data acquirement and
analysis. FOF conceived the study, and participated in its coordination. BMR
conceived of the study, and participated in its design. DMC participated in
its experimental design and coordination and helped to draft the
manuscript. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 6 July 2011 Accepted: 30 September 2011
Published: 30 September 2011
References
1. Al-Tassan N, Chmiel NH, Maynard J, Fleming N, Livingston AL, Williams GT,
Hodges AK, Davies DR, David SS, Sampson JR, Cheadle JP: Inherited
variants of MYH associated with somatic G:C– > T:A mutations in
colorectal tumors. Nat Genet 2002, 30(2):227-32.
Figure 3 Short interspersed nucleotide element (SINE) content of the MUTYH genomic region (chr1:45794343-45806142) (data from
UCSC database and RepeatMasker). A region of 11.8 kb is shown, extending 571 bp downstream of the MUTYH gene. Vertical bars in the
genomic sequence indicate exons. The direction of the arrowheads denotes the orientation of the SINE repeat elements and each family is
represented by a different color (Red: AluJ, Blue: AluS, Green: MIR, Purple: FLAM_C). The black arrow indicates the AluJr element involved in the
distal breakpoint; no repetitive element is present on the proximal breakpoint.
Torrezan et al. BMC Medical Genetics 2011, 12:128
http://www.biomedcentral.com/1471-2350/12/128
Page 5 of 62. Out AA, Tops CMJ, Nielsen ÃM, Weiss MM, Minderhout IJHMV,
Fokkema IFAC, Buisine M-Pierre, Claes K, Colas C, Fodde R, Fostira F,
Franken PF, Gaustadnes M, Heinimann K, Hodgson SV, Hogervorst FBL,
Holinski-feder E, Lagerstedt-robinson K, Olschwang S, Ouweland AMWVD,
Redeker EJW, Scott RJ, Vankeirsbilck B, Grønlund RV, Wijnen JT, Wikman FP,
Aretz S, Sampson JR, Devilee P, Dunnen JTD, Hes FJ: Leiden Open
Variation Database of the MUTYH Gene Human Mutation. Hum Mutat
2010, 31(11):1205-1215.
3. Nghiem Y, Cabrera M, Cupples CG, Miller JH: The mutY gene: a mutator
locus in Escherichia coli that generates G.C——T.A transversions. PNAS
1988, 85(8):2709-13.
4. Sampson JR, Jones S, Dolwani S, Cheadle JP: MutYH (MYH) and colorectal
cancer. Biochem Soc Trans 2005, 33(4):679-683.
5. Nielsen M, Morreau H, Vasen HFA, Hes FJ: MUTYH-associated polyposis
(MAP). Crit Rev Oncol Hematol 2010, 1-16.
6. Sampson JR, Dolwani S, Jones S, Eccles D, Ellis A, Evans DG, Frayling I,
Jordan S, Maher ER, Mak T, Maynard J, Pigatto F, Shaw J, Cheadle JP:
Autosomal recessive colorectal adenomatous polyposis due to inherited
mutations of MYH. Lancet 2003, 362(9377):39-41.
7. Filipe B, Baltazar C, Albuquerque C, Fragoso S, Lage P, Vitoriano I, Mão de
Ferro S, Claro I, Rodrigues P, Fidalgo P, Chaves P, Cravo M, Nobre Leitão C:
APC or MUTYH mutations account for the majority of clinically well-
characterized families with FAP and AFAP phenotype and patients with
more than 30 adenomas. Clin Genet 2009, 76:242-255.
8. Aretz S, Hes FJ: Clinical utility gene card for: MUTYH-associated polyposis
(MAP), autosomal recessive colorectal adenomatous polyposis. Eur J Hum
Genet 2010, 2-4.
9. Pitroski CE, Cossio SL, Koehler-Santos P, Graudenz M, Prolla JC, Ashton-
prolla P: Frequency of the common germline MUTYH mutations p.G396D
and p.Y179C in patients diagnosed with colorectal cancer in Southern
Brazil. Int J Colorectal Dis 2011, 3:1-16.
10. Rouleau E, Zattara H, Lefol C, Noguchi T, Briaux A, Buecher B, Bourdon V,
Sobol H, Lidereau R, Olschwang S: First large rearrangement in the
MUTYH gene and attenuated familial adenomatous polyposis syndrome.
Clin Genet 2011, 80:301-303.
11. Abeysinghe SS, Chuzhanova N, Krawczak M, Ball EV, Cooper DN:
Translocation and gross deletion breakpoints in human inherited
disease and cancer I: Nucleotide composition and recombination-
associated motifs. Hum Mutat 2003, 22(3):229-44.
12. Korbel JO, Urban AE, Affourtit JP, Godwin B, Grubert F, Simons JF, Kim PM,
Palejev D, Carriero NJ, Du L, Taillon BE, Chen Z, Tanzer A, Saunders ACE,
Chi J, Yang F, Carter NP, Hurles ME, Weissman SM, Harkins TT, Gerstein MB,
Egholm M, Snyder M: Paired-End Mapping Reveals Extensive Structural
Variation in the Human Genome. Science 2007, 420(318):420-426.
13. Perry GH, Ben-dor A, Tsalenko A, Sampas N, Rodriguez-revenga L, Tran CW,
Scheffer A, Steinfeld I, Tsang P, Yamada NA, Park HS, Kim J-il, Seo J-sun,
Yakhini Z, Laderman S, Bruhn L, Lee C: The Fine-Scale and Complex
Architecture of Human Copy-Number Variation. Am J Hum Genet 2008,
82:685-695.
14. Linardopoulou EV, Williams EM, Fan Y, Friedman C, Young JM, Trask BJ:
Human subtelomeres are hot spots of interchromosomal recombination
and segmental duplication. Nature 2005, 437:94-100.
15. Chan CY, Kiechle M, Manivasakam P, Schiestl RH: Ionizing radiation and
restriction enzymes induce microhomology-mediated illegitimate
recombination in Saccharomyces cerevisiae. Nuc Ac Res 2007,
35(15):5051-9.
16. Weaver DT, DePamphilis ML: Specific Sequences in Native DNA that
Arrest Synthesis by DNA Polymerase a. Biol Chem 1982, 257(4):2075-2086.
17. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K,
Dewar K, Doyle M, FitzHugh W, Funke R, Gage D, Harris K, Heaford A,
Howland J, Kann L, Lehoczky J, LeVine R, McEwan P, McKernan K,
Meldrim J, Mesirov JP, Miranda C, Morris W, Naylor J, Raymond C, Rosetti M,
Santos R, Sheridan A, Sougnez C, et al: Initial sequencing and analysis of
the human genome. Nature 2001, 409(6822):860-921.
18. Zelm MCV, Geertsema C, Nieuwenhuis N, Ridder DD, Conley ME, Schiff C,
Tezcan I, Bernatowska E, Hartwig NG, Sanders EAM, Litzman J,
Kondratenko I, Dongen JJMV, Burg MVD: Gross Deletions Involving IGHM,
BTK, or Artemis: A Model for Genomic Lesions Mediated by
Transposable Elements. J Hum Genet 2008, , 82: 320-332.
19. Franke G, Bausch B, Hoffmann MM, Cybulla M, Wilhelm C, Kohlhase J,
Scherer G, Neumann HPH: Alu-Alu recombination underlies the vast
majority of large VHL germline deletions: Molecular characterization and
genotype-phenotype correlations in VHL patients. Hum Mutat 2009,
30(5):776-86.
20. Kuiper RP, Vissers LELM, Venkatachalam R, Bodmer D, Hoenselaar E,
Goossens M, Haufe A, Kamping E, Niessen RC, Hogervorst FBL, Gille JJP,
Redeker B, Tops CMJ, van Gijn ME, van den Ouweland AMW, Rahner N,
Steinke V, Kahl P, Holinski-Feder E, Morak M, Kloor M, Stemmler S, Betz B,
Hutter P, Bunyan DJ, Syngal S, Culver JO, Graham T, Chan TL, Nagtegaal ID,
et al: Recurrence and variability of germline EPCAM deletions in Lynch
syndrome. Hum Mutat 2011, 32(4):407-14.
21. Resta N, Giorda R, Bagnulo R, Beri S, Della Mina E, Stella A, Piglionica M,
Susca FC, Guanti G, Zuffardi O, Ciccone R: Breakpoint determination of 15
large deletions in Peutz-Jeghers subjects. Hum Genet 2010, 128(4):373-82.
22. Batzer MA, Deininger PL: Alu repeats and human genomic diversity. Nat
Rev Genet 2002, 3:370-379.
23. Chen H, Sun C, Guo W, Meng R, Du H, Qi Q, Gu X, Li L, Zhang K, Zhu D,
Wang Y: AluYb8 insertion in the MUTYH gene is related to increased 8-
OHdG in genomic DNA and could be a risk factor for type 2 diabetes in
a Chinese population. Mol Cell Endocrinol 2011, 332:301-305.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2350/12/128/prepub
doi:10.1186/1471-2350-12-128
Cite this article as: Torrezan et al.: Breakpoint characterization of a novel
large intragenic deletion of MUTYH detected in a MAP patient: Case
report. BMC Medical Genetics 2011 12:128.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Torrezan et al. BMC Medical Genetics 2011, 12:128
http://www.biomedcentral.com/1471-2350/12/128
Page 6 of 6